Hypoxic-ischemic encephalopathy is one of the most notable causes of brain injury in newborns. Cerebral ischemia and reperfusion lead to neuronal damage and neurological disability. In vitro and in vivo analyses have indicated that E3 ubiquitin protein ligase (Huwe1) is important for the process of neurogenesis during brain development; however, the exact biological function and the underlying mechanism of Huwe1 remain controversial. In the present study, neural progenitor cells, L2.3, of which we previously generated from rat E14.5 cortex, were used to investigate the role of Huwe1 and its effects on the downstream N-Myc-Delta-like 3-Notch1 signaling pathway during oxygen-glucose deprivation (OGD). To evaluate the role of Huwe1 in L2.3 cells, transduction, cell viability, lactate dehydrogenase, 5-bromo-2'deoxyurine incorporation, western blotting and immunocytochemical assays were performed. The results of the present study indicated that Huwe1 rescued L2.3 cells from OGD-induced insults by inhibiting proliferation and inducing neuronal differentiation. In addition, Huwe1 was suggested to mediate the survival of L2.3 cells by inhibiting the activation of the N-Myc-Notch1 signaling pathway. Of note, the effects of Huwe1 on Notch1 signaling were completely abolished by knockdown of N-Myc, indicating that Huwe1 may require N-Myc to suppress the activation of the Notch1 signaling in L2.3 cells. The determination of the neuroprotective function of the Huwe1-N-Myc-Notch1 axis may provide insight into novel potential therapeutic targets for the treatment of ischemic stroke.
Introduction
Hypoxic-ischemic encephalopathy is a type of brain injury within newborns, in which cerebral ischemia and reperfusion lead to neuronal damage and neurological disability (1, 2) . Increasing evidence has suggested that neuronal injury induces the proliferation and differentiation of neural stem cells/progenitor cells (NSCs/NSPs) and adult neurogenesis (3) (4) (5) . NSPs possess a notable ability to self-renew and differentiate into glia and functional neurons (6, 7) . Animal and clinical studies (8) have suggested that NSPs are a powerful potential treatment for numerous diseases of the central nervous system (9) (10) (11) . Specifically, it has been reported that NSPs are involved in the regeneration of neurons and glia during perinatal hypoxia/ischemia (H/I) (12) .
Numerous signaling pathways are involved in the regulation of NSCs (13) (14) (15) (16) . N-Myc, which is mainly distributed in the developing nervous system, is predominantly expressed in NSCs and neuroectodermal progenitors under normal conditions (17, 18) . In addition, N-Myc is required for the development of the nervous system; loss of N-Myc function results in the failure of neural progenitor cell expansion (19) . Notch signaling has been associated with the regulation of NSCs; the Notch signaling pathway promotes the survival and proliferation of normal and tumor-derived NSCs, and prevents their differentiation (20) (21) (22) . Binding of the ligands Delta or Jagged to Notch receptors induces the intramembranous proteolytic cleavage of the Notch receptor, yielding an activated Notch intracellular domain (NICD), which is necessary for the regulation of the transcription of several target genes, such as fibroblast growth factor 5 (23) .
By using mass spectrometry, E3 ubiquitin protein ligase (Huwe1), containing a HECT domain, was purified from H1299 cells transfected with a plasmid expressing HA-ARF-Flag (24) . Huwe1 has numerous substrates, including N-Myc, p53 and cell division cycle 6 (25) (26) (27) (28) (29) . It has been demonstrated that Huwe1 is important for the transition from NSCs/NSPs to differentiated neurons (27) . Loss of Huwe1 severely disrupts neurogenesis and the laminar organization in the cortex and, interestingly, the N-Myc-Delta-like 3 (DLL3)-Notch1 signaling cascade has been reported to be involved in this process (27, 30) . In vitro and in vivo research has indicated that Huwe1 is a key factor for neurogenesis; however, the exact biological function and underlying mechanism of Huwe1 remains controversial: Huwe1 affects the accumulation of many substrates, including N-Myc, c-Myc and Mcl1, which are involved in carcinogenesis. However, Huwe1 also promotes the accumulation of p53 protein, which inhibits the growth and development of multiple cancer types.
We previously generated neural progenitor L2.3 cells from a rat E14.5 cortex with the ability to differentiate into neurons, astrocytes, oligodendrocytes and other neuronal cell types (31, 32) . In the present study, radial glial L2.3 cells were used to inves tigate the role of Huwe1 and the downstream N-Myc-DLL3-Notch1 signaling pathway during oxygen-glucose deprivation (OGD) and the restoration of normal conditions.
Materials and methods
Cell culture. The culturing conditions of L2.3 cells were described previously (32) . Briefly, L2.3 cells were cultured as neurospheres for 3 to 4 days in culture medium: Dulbecco's modified Eagles medium/F12 (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 25 mM glucose (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany), 2 mM glutamine, 100 units/ml penicillin and 0.1 mg/ml streptomycin (both Invitrogen; Thermo Fisher Scientific, Inc.), 10 ng/ml fibroblastic growth factor 2 (FGF2; BD Biosciences, San Jose, CA, USA), 2 µg/ml heparin (Sigma-Aldrich; Merck KGaA) and 1X B27 (Invitrogen; Thermo Fisher Scientific, Inc.). Cells were propagated as neurospheres and passaged by mild trypsinization (0.025% for 5 min at 37˚C with 5% CO 2 ) every 3 days. Cells (1x10 4 ) were cultured on laminin-coated coverslips in 10 ng/ml FGF2-containing serum-free culture medium (DMEM/F12 with 25 mM glucose, 2 mM glutamine, 100 units/ml penicillin, 0.1 mg/ml streptomycin, 10 ng/ml FGF2, 2 µg/ml heparin and 1X B27) for 2 days at 37˚C prior to transduction with a lentiviral vector (described below). For differentiation, cells were cultured on laminin-coated coverslips in 10 ng/ml FGF2-containing serum-free medium for 1 day, then the medium was replaced with FGF2-free culture medium with fetal bovine serum (1%) (Gibco; Thermo Fisher Scientific, Inc.) for 5 days. The cells were then fixed and stained with specific antibodies as described below.
Establishment of the OGD-injured L2.3 cell model. OGD was conducted to induce H/I in vitro. Cells (~1x10 4 ) were washed three times with glucose-free culture medium (DMEM/F12 with 2 mM glutamine, 100 units/ml penicillin and 0.1 mg/ml streptomycin, 10 ng/ml FGF2, 2 µg/ml heparin and 1X B27) prior to oxygen deprivation and placed in an anaerobic chamber, then perfused with N 2 (95%) and CO 2 (5%) at 37˚C for 6 h. Following OGD, the cells were transferred to the aforementioned culture medium and cultured with CO 2 (5%) at 37˚C for the normalization of oxygen and glucose levels for 8, 16 and 24 h. Cells cultured under normoxic conditions were considered the control group.
Lentiviral constructs and transduction. GIPZ lentiviral microRNA-adapted short hairpin (sh)RNA vectors (sequences unavailable; expressing control non-silencing shRNA, rat Huwe1 shRNA and N-Myc shRNA, respectively) were obtained from Open Biosystems, Inc. (Thermo Fisher Scientific, Inc.). In accordance with the Trans-Lentiviral packaging system (Open Biosystems, Inc.; Thermo Fisher Scientific, Inc.), lentiviral packaging was conducted using 5.0x10 5 TLA-293T cells (Open Biosystems; GE Healthcare Dharmacon, Inc., Lafayette, CO, USA). The DMEM/F12 medium containing the packaging plasmids was aspirated and replaced with complete medium (DMEM/F12 containing 20% FBS) 12 h following transfection. The cell supernatant, containing the lentivirus was collected after 72 h, centrifuged at 12,000 x g and 4˚C for 20 min and stored at -80˚C. To determine the titers of lentiviral particles in the isolated supernatants, TLA-293T cells were transduced with serial dilutions (5X, 10X, 20X) of the lentiviral supernatants (500 x g at 4˚C for 10 min) for 48 h and were identified by green fluorescent protein fluorescence and sorted on a BD FACS Aria II (BD Biosciences). As determined by trypan blue staining technique, the viability of cells after cell sorting was higher than 95%. (33) (x4 magnification, 488 nm excitation). L2.3 cells were transduced with lentiviral particles (Huwe1 shRNA or Huwe1 shRNA and N-Myc shRNA) diluted (2X, 5X) in serum free medium containing 10 µg/ml of Polybrene ® (Merck KGaA) at a multiplicity of infection (MOI) of 10, all carrying green fluorescent protein (GFP). After 6 h, an equal amount (1 ml) of culture medium was added to each well. The transduction cocktail was removed and replaced with complete medium containing puromycin (2 µg/ml) the following day, and western blot analysis for Huwe1 and N-Myc expression in cell lysates was performed to select for Huwe1 shRNA-transfected cells or Huwe1 and N-Myc shRNA-transfected cells. Control shRNA-transfected cells and untransfected cells were used as the controls.
Cell viability assay. A Cell Counting Kit-8 (Dojindo Molecular
Technologies, Inc., Kumamoto, Japan) was used to assess cell viability: 100 µl of the L2.3 cell suspension (in PBS) was seeded in 96-well plates (50,000 cells/well). Untransfected cells were used as the control. The kit was utilized according to the manufacturer's protocols; the absorbance at 450 nm was measured with a microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA). Cell viability was calculated by setting the absorbance of the normoxic control to 100%.
Lactate dehydrogenase (LDH) release assay. LDH release in the culture medium was measured using an LDH diagnostic kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China), according to the manufacturer's protocols. LDH activity was calculated in 96-well plates (5x10 4 cells/well) by measuring the absorbance at 490 nm with a microplate reader (Bio-Rad Laboratories, Inc.).
5-bromo-2'deoxyurine (BrdU) assay.
Cells were treated with 10 µM BrdU (Roche Diagnostics, Sussex, UK) for 24 h. Spheres were dissociated with 10 mg/ml collagenase for 10 min at room temperature and ~2x10 4 cells were fixed with a formalin solution for 15 min at 37˚C on a Matrigel-coated coverslip (incubated overnight with Matrigel at 37˚C). Following permeabilization with PBS containing Triton X-100 (0.1%) at room temperature for 30 min, DNA denaturation was performed with 2N HCl for 10 min at room temperature, followed by neutralization with 0.1 M sodium tetra-borate for 10 min at room temperature. The subsequent steps conducted were described below in 'Immunocytochemistry'. Genome-integrated BrdU was detected using an anti-BrdU antibody (1:200; cat. no 555627; BD Biosciences) and a Cy3 conjugated anti-mouse secondary antibody (1:1,000; cat. no. 115-165-003; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA). The proportion of BrdU positive cells relative to the total number of cells was estimated using a fluorescent microscope (x10 magnification, 550 nm excitation). Three fields of view were analyzed. (1:1,000; cat. no. AB8925; Cell Signaling Technology, USA), DLL3 (1:200, Abcam, USA, cat. no. ab103102), N-Myc (1:200; cat. no. ab24193) at 4˚C overnight, and then with anti-rabbit horseradish peroxidase-conjugated secondary antibody (1:1,000; cat. no. ab6721; Abcam) at 37˚C for 1 h. The blots were developed using an enhanced chemiluminescence detection system (Merck KGaA). An anti-GAPDH antibody (mouse IgG; cat. no. ab70699; 1:1,000; Abcam) was used to detect GAPDH and normalize the sample loading. The western blot image was analyzed by Bio-Rad Image Lab 4.1 (Bio-Rad Laboratories, Inc.). Experiments were performed three times.
Immunocytochemistry. L2.3 cells underwent expansion for
Statistical analysis. For comparisons among multiple groups, one-way analysis of variance followed by Fisher's Least Significant Difference method was performed to determine the statistical differences between groups by using the SPSS 15.0 software. All data were expressed as the mean ± standard deviation of three experiments. P<0.05 was considered to indicate a statistically significant difference.
Results

Huwe1 knockdown decreases cell viability after 6 h.
We previously reported that, upon the onset of OGD, the viability of L2.3 cells progressively decreased; the cell number was significantly lower after 6 h (P<0.001, n=3) (34) . Accordingly, in the present study, 6 h was selected as the duration of OGD. To investigate whether Huwe1 serves a key role in OGD, the expression levels of Huwe1 in L2.3 cells exposed to OGD for 6 h were determined, followed by the restoration of normal conditions at 8, 16 and 24 h (Fig. 1A) . Quantification of Huwe1 protein expression levels were normalized to GAPDH (Fig. 1B) . The results revealed that the expression levels of Huwe1 were significantly increased in OGD-treated L2.3 cells compared with cells unexposed to OGD.
To evaluate the role of Huwe1 in L2.3 cells, GIPZ shRNA lentiviral vectors were employed to knockdown Huwe1 expression in L2.3 cells (Fig. 1C) as aforementioned. Accordingly, knockdown of Huwe1 expression was associated with significant reductions in the viability of L2.3 cells exposed ; the number of cells in each condition was normalized to the control conditions. Data are presented as the mean ± standard error from more than three independent experiments. * P<0.05 vs. the normal control. BrdU, 5-bromo-2'deoxyurine; Huwe1, E3 ubiquitin protein ligase; MAP2, microtubule-associated protein 2; OGD, oxygen-glucose deprivation; shRNA, short hairpin RNA.
to OGD (Fig. 1D) ; LDH release was significantly elevated compared with in OGD control and OGD control shRNA cells (Fig. 1E) . The data indicated that Huwe1 may be required to maintain L2.3 cell viability following the onset of OGD. To further evaluate whether N-Myc is involved in Huwe1-mediated survival of L2.3 cells during OGD, the cell viability and LDH release in N-Myc-silenced L2.3 cells were determined. The results revealed that the downregulation of N-Myc expression reduced LDH release and increased cell viability compared with in the normal control and OGD control shRNA groups (Fig. 1D and E) .
Huwe1 knockdown induces nestin expression and the proliferation of L2.3 cells.
The present study analyzed the expression of nestin and MAP2 in L2.3 cells to determine whether cell proliferation led to cell differentiation. L2.3 cells underwent expansion for 5 days under normal condition or following OGD, and were stained with neural precursor cell marker nestin (green), neuronal marker MAP2 (red) and DAPI (blue). As presented in Fig. 2A and B , a significant increase in the number of MAP2 + cells was detected following OGD exposure compared with in the normal control conditions. Knockdown of Huwe1 expression induced a significant increase in the percentage of nestin + cells and a decrease in MAP2 + precursor cells (35) under normal and OGD conditions.
To determine whether the reduced viability of Huwe1-silenced L2.3 cells was due to the inhibition of proliferation, BrdU incorporation assays were conducted. The results of the present study revealed that BrdU + cells were more abundant in the control than under the OGD condition; notably fewer BrdU + . A significantly greater number of Huwe1-silenced cells were observed in OGD condition compared with in normal conditions (Fig. 2C ). This indicated that, under normal conditions, a higher percentage of actively dividing cells may be detected. The results were consistent with the onset of cell proliferation, suggesting that Huwe1 may inhibit the proliferation in L2.3 cells.
OGD/restoration (OGD/R) inhibits N-Myc-DLL3-Notch signaling in L2.3 cells.
The potential mechanisms underlying the effects of Huwe1 in the neuronal differentiation of L2.3 cells were investigated in the present study. As presented in Fig. 1A , the expression levels of Huwe1 began to increase significantly after 16 h following the restoration of normal conditions. Therefore, 16 h was selected as the duration of restoration for the normal culture conditions. The results demonstrated that the expression levels of Notch1, NICD, DLL3 and N-Myc were significantly increased following exposure to OGD for 6 h and decreased after restoration for 16 h (OGD/R) compared with in the normal control ( Fig. 3A and B) . The results suggested that OGD/R may inhibit Notch signaling. Additionally, Notch1-transcriptional activity was analyzed via a luciferase reporter assay, which revealed a significant decrease in Notch1 activation when L2.3 cells were exposed to OGD/R compared with in the normal control (Fig. 3C ). These results further indicated that Notch signaling may be associated with cell fate.
Huwe1 mediates the survival of L2.3 cells via the N-Myc-Notch1
signaling pathway during OGD and restoration. To evaluate whether Huwe1 affects the Notch1 signaling pathway, Huwe1 was downregulated in L2.3 cells, which were exposed to OGD for 6 h and restoration for 16 h. The results demonstrated that N-Myc and the components of the Notch1 signaling pathway, including Notch1, NICD and DLL3 were significantly upregulated following the knockdown of Huwe1 compared with in the control groups ( Fig. 4A and B) . Additionally, knockdown of N-Myc expression in L2.3 cells was conducted (Fig. 4C) , which revealed that the expression levels of the Notch1 signaling pathway components were not altered following knockdown of both Huwe1 and N-Myc expression ( Fig. 4D and E) . These results indicated that Huwe1 may require N-Myc to suppress the activation of the Notch1 signaling in L2.3 cells during OGD and the restoration of normal conditions.
Discussion
To the best of our knowledge, the present study is the first to report the protective role of Huwe1 in L2.3 cells under the OGD condition. Specifically, Huwe1 was observed to rescue L2.3 cells from OGD-induced injury by inhibiting proliferation and inducing neuronal differentiation. Subsequently, its effects on the downstream N-Myc-Delta-like 3-Notch1 signaling pathway were investigated to explore the underlying mechanisms. Mechanistically, it was demonstrated that Huwe1 mediated the survival of L2.3 cells via inhibition of the N-Myc-Notch1 signaling axis in the present study. Thus, in response to OGD and the restoration of normal conditions, Huwe1 was proposed to inhibit the N-Myc-Notch1 signaling axis and induce the differentiation of L2.3 cells in the present study. In addition, the effects of Huwe1 on Notch1 signaling were notably abolished via the knockdown of N-Myc. Therefore, the findings of the present study indicated that the Huwe1-N-Myc-Notch1 axis may be a novel neuroprotective pathway associated with ischemic stroke.
Huwe1 is important for neurogenesis (30) ; however, the biological function of Huwe1 in neurological diseases remains unknown (36) . The present study reported that Huwe1 served a role in the survival of L2.3 cells under the OGD condition, which suggests Huwe1 as a potential target in the treatment of ischemic stroke. Consistent with the role of Huwe1 on the transition from NSCs to differentiated neurons, Huwe1 may improve the neurobehavioral outcomes following ischemic brain injury by enhancing neuronal differentiation and rescuing cells from OGD-induced insults. Previous studies have reported that Huwe1 acts via the N-Myc-DLL3-Notch1 signaling pathway during neural development (27, 30) . Huwe1 was reported to suppress the N-Myc-DLL3 cascade associated with the initiation of neurogenesis in the developing brain, and negatively regulated the expression of DLL3 in an N-Myc-dependent manner, and the activation Notch1, a transmembrane receptor on the surface of neural progenitors, was proposed to be involved in NSC maintenance (37, 38) . When activated by the ligands of neighboring cells, NICD translocates to the nucleus and activates transcription (39) . In the developing brain, activated Notch signaling maintains the state of NSCs by promoting the proliferation of neural progenitors and inhibiting the differentiation progenitor cells into neurons (40) . In support of this, a study indicated that attenuation of Notch signaling promoted the differentiation of neural progenitors in the subacute phase following ischemia (41) . In conclusion, Huwe1 may protect neural progenitors L2.3 cells from injury associated with OGD and the restoration of normal conditions; however, further investigation is required to evaluate the pathological mechanism underlying the protective effects of Huwe1 in the acute phase of stroke.
